Lappe Mark

CIK 00013660743 companiesLA JOLLA, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001366074

Recent Transactions

50 trades

Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-21$12.93/sh+12,945→ 54,865 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-21$12.93/sh+12,945→ 54,865 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-20$12.97/sh+27,055→ 41,920 total
Purchase
Inhibrx Biosciences, Inc.$INBX
Common Stock
2024-08-20$12.97/sh+27,055→ 41,920 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$25.71/sh−4,272→ 2,486,315 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-24$26.11/sh−63→ 2,486,252 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Sale
Inhibrx, Inc.
Common Stock
2023-01-23$25.36/sh−21,665→ 2,490,587 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Award
Inhibrx, Inc.
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-31$9.43/sh+54,100→ 2,371,013 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-28$9.32/sh+70,000→ 2,316,913 total
Purchase
REPROS THERAPEUTICS INC.
Common Stock
2007-12-19$9.84/sh+43,500

Companies

Recent Filings

Address

C/O INHIBRX, INC. 11025 NORTH TORREY PINES ROAD, SUITE 200

LA JOLLA, CA, 92037

View on SEC.gov